CC
STJ

ClearArc Capital’s St Jude Medical STJ Stock Holding History

ClearArc Capital’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,953
Closed -$558K – 463
2016
Q4 		$558K Sell
6,953
-49
-0.7% -$3.89K 0.1% 220
2016
Q3 		$558K Buy
7,002
+93
+1% +$7.51K 0.11% 218
2016
Q2 		$539K Sell
6,909
-30
-0.4% -$2.14K 0.1% 216
2016
Q1 		$382K Buy
6,939
+23
+0.3% +$1.25K 0.08% 275
2015
Q4 		$427K Buy
6,916
+62
+0.9% +$3.91K 0.09% 260
2015
Q3 		$432K Sell
6,854
-81
-1% -$5.78K 0.09% 261
2015
Q2 		$507K Buy
6,935
+841
+14% +$60.8K 0.09% 251
2015
Q1 		$399K Sell
6,094
-19
-0.3% -$1.26K 0.08% 284
2014
Q4 		$398K Buy
6,113
+242
+4% +$15.6K 0.08% 278
2014
Q3 		$353K Buy
5,871
+167
+3% +$10.9K 0.08% 270
2014
Q2 		$395K Buy
5,704
+82
+1% +$5.32K 0.09% 243
2014
Q1 		$368K Buy
5,622
+178
+3% +$11.6K 0.09% 254
2013
Q4 		$337K Sell
5,444
-10
-0.2% -$579 0.09% 252
2013
Q3 		$293K Buy
5,454
+12
+0.2% +$618 0.08% 273
2013
Q2 		$248K Buy
+5,442
New +$236K 0.07% 312

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

ClearArc Capital's STJ Position: Q1 2017 in Review

ClearArc Capital sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 6,953 shares — an estimated $558K sold.

ClearArc Capital first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $558K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • ClearArc Capital reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • ClearArc Capital sold 6,953 St Jude Medical shares in Q1 2017, an estimated $558K.
  • ClearArc Capital first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • ClearArc Capital's St Jude Medical position peaked at $558K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on ClearArc Capital's 13F filing for Q1 2017, filed 12 May 2017.